Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VALacyclovir for Inflammation AttenuatioN Trial Pilot (VALIANT Pilot)

NCT01176409 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01176409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01176409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VALacyclovir for Inflammation AttenuatioN Trial Pilot (VALIANT Pilot)
Lead sponsor
University Health Network, Toronto
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
August 31, 2013
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex, human immunodeficiency virus